These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24599316)

  • 1. Antipsychotic, antidepressant, and cognitive-impairment properties of antipsychotics: rat profile and implications for behavioral and psychological symptoms of dementia.
    Kołaczkowski M; Mierzejewski P; Bienkowski P; Wesołowska A; Newman-Tancredi A
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Jun; 387(6):545-57. PubMed ID: 24599316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADN-1184 a monoaminergic ligand with 5-HT(6/7) receptor antagonist activity: pharmacological profile and potential therapeutic utility.
    Kołaczkowski M; Mierzejewski P; Bieńkowski P; Wesołowska A; Newman-Tancredi A
    Br J Pharmacol; 2014 Feb; 171(4):973-84. PubMed ID: 24199650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional 6-fluoro-3-[3-(pyrrolidin-1-yl)propyl]-1,2-benzoxazoles targeting behavioral and psychological symptoms of dementia (BPSD).
    Bucki A; Marcinkowska M; Śniecikowska J; Zagórska A; Jamrozik M; Pawłowski M; Głuch-Lutwin M; Siwek A; Jakubczyk M; Pytka K; Jastrzębska-Więsek M; Partyka A; Wesołowska A; Mierzejewski P; Kołaczkowski M
    Eur J Med Chem; 2020 Apr; 191():112149. PubMed ID: 32105980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test.
    Ishiyama T; Tokuda K; Ishibashi T; Ito A; Toma S; Ohno Y
    Eur J Pharmacol; 2007 Oct; 572(2-3):160-70. PubMed ID: 17662268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The drug-induced helplessness test: an animal assay for assessing behavioral despair in response to neuroleptic treatment.
    Ballard ME; Basso AM; Gallagher KB; Browman KE; Fox GB; Drescher KU; Gross G; Decker MW; Rueter LE; Zhang M
    Psychopharmacology (Berl); 2007 Jan; 190(1):1-11. PubMed ID: 17093979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity.
    Qin R; Chen Y; Li M
    Neuropharmacology; 2013 Dec; 75():356-64. PubMed ID: 23954676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. II. Preclinical behavioral effects.
    Corbin AE; Meltzer LT; Ninteman FW; Wiley JN; Christoffersen CL; Wustrow DJ; Wise LD; Pugsley TA; Heffner TG
    Neuropharmacology; 2000 Apr; 39(7):1211-21. PubMed ID: 10760363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: II. behavioural characterisation of RG-15.
    Gyertyán I; Sághy K; Laszy J; Elekes O; Kedves R; Gémesi LI; Pásztor G; Zájer-Balázs M; Kapás M; Agai Csongor E; Domány G; Kiss B; Szombathelyi Z
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Nov; 378(5):529-39. PubMed ID: 18548231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically.
    Brown JW; Rueter LE; Zhang M
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():53-62. PubMed ID: 24269664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tail suspension test does not detect antidepressant-like properties of atypical antipsychotics.
    Wesołowska A; Partyka A; Jastrzębska-Więsek M; Kolarz A; Mierzejewski P; Bieńkowski P; Kołaczkowski M
    Behav Pharmacol; 2011 Feb; 22(1):7-13. PubMed ID: 21127415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats.
    Enomoto T; Ishibashi T; Tokuda K; Ishiyama T; Toma S; Ito A
    Behav Brain Res; 2008 Jan; 186(2):197-207. PubMed ID: 17881065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel arylsulfonamide derivatives with 5-HT₆/5-HT₇ receptor antagonism targeting behavioral and psychological symptoms of dementia.
    Kołaczkowski M; Marcinkowska M; Bucki A; Pawłowski M; Mitka K; Jaśkowska J; Kowalski P; Kazek G; Siwek A; Wasik A; Wesołowska A; Mierzejewski P; Bienkowski P
    J Med Chem; 2014 Jun; 57(11):4543-57. PubMed ID: 24805037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of selective antagonists of serotonin 5-HT7 and 5-HT1A receptors on MK-801-induced impairment of learning and memory in the passive avoidance and Morris water maze tests in rats: mechanistic implications for the beneficial effects of the novel atypical antipsychotic lurasidone.
    Horisawa T; Ishibashi T; Nishikawa H; Enomoto T; Toma S; Ishiyama T; Taiji M
    Behav Brain Res; 2011 Jun; 220(1):83-90. PubMed ID: 21277905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GLP-1 receptor agonist liraglutide reverses long-term atypical antipsychotic treatment associated behavioral depression and metabolic abnormalities in rats.
    Sharma AN; Ligade SS; Sharma JN; Shukla P; Elased KM; Lucot JB
    Metab Brain Dis; 2015 Apr; 30(2):519-27. PubMed ID: 25023888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity.
    Siuciak JA; Chapin DS; McCarthy SA; Guanowsky V; Brown J; Chiang P; Marala R; Patterson T; Seymour PA; Swick A; Iredale PA
    Neuropharmacology; 2007 Feb; 52(2):279-90. PubMed ID: 16949622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models.
    Natesan S; Reckless GE; Nobrega JN; Fletcher PJ; Kapur S
    Neuropsychopharmacology; 2006 Sep; 31(9):1854-63. PubMed ID: 16319908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.